CytomX Therapeutics Inc (NASDAQ:CTMX) traded at $2.11 at close of the session on Friday, June 20 and made an upward move of 2.32% on its previous day’s price.
Looking at the stock we see that its previous close was $5.50 and the beta (5Y monthly) reads 2.12 with the day’s price range being $2.15 – $2.375. The company has a trailing 12-month PE ratio of 4.68. In terms of its 52-week price range, CTMX has a high of $25.04% and a low of $3.10. The company’s stock has gained about 12.62% over that past 30 days.
CytomX Therapeutics Inc has a market cap of $365.50 million and is expected to release its quarterly earnings report on 2025-May-12.
Based on estimates by 4 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the CytomX Therapeutics Inc (CTMX) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 121 off its SMA20 and 0.11 from its 50-day simple moving average. The beta value is 37.28%, while the average true range (ATR) is currently pointing at -71.14%. The average price target for the stock over the next 12 months is $5.84, with the estimates having a low of $3.25 and a high of $8. These price ends are -54.03% and -279.15% off the current price level respectively, although investors could be excited at the prospect of a -176.78% if the CTMX share price touches on the median price of $5.84.
Coming back to CytomX Therapeutics Inc (NASDAQ:CTMX), we note that the average 3-month trading volume was 1.70, while that of the preceding 10-day period stands at 3.32 million. Current shares outstanding are 157.54 million.
The insiders hold 33.81% of the company’s shares while institutions hold 35.39%. The data shows that short shares as of 2025-05-30, stood at 18.96 million at a short ratio of 1.78. This represents a 1250.00 short interest in shares outstanding on 2025-05-30. Shares short rose in May from the previous month at 9.74 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 69.34% up in year-to-date price movement.
